Associate, Corporate Development

Job Details

Location:
New York, NY
Department:
Finance
Posted Date:
Oct. 13, 2021

Job Summary

Roivant's mission is to systematically reduce the time, cost, and risk of delivering new medicines to market by accelerating the development of promising drug candidates to improve the lives of patients and their families. The company is publicly listed, has in-licensed 25+ assets, and is very well-capitalized. The Corporate Development team is responsible for generating, pursuing, and leading strategic mergers, acquisitions, and collaborations on behalf of the Vant family of portfolio companies.

Since its inception in 2014, Roivant Sciences has sought to improve health by rapidly delivering innovative medicines and technologies to patients. We've employed a unique, decentralized model of nimble, focused companies (‘Vants') focused on various therapeutic areas and built around the pursuit of innovation in drug development. Roivant's model has established a proven record of efficient drug development and company creation, with results including: >40 medicines brought into development, 8 positive Phase 3 readouts of 9 total, and 4 FDA approvals for Vants launched by Roivant after their sale to DSP. In late 2019, Roivant concluded a major transaction with Japan's Sumitomo Dainippon Pharma (‘DSP'), in which DSP paid $3bn to acquire Roivant's interest in 5 of the Vants it had previously built, as well as taking an 11% equity stake in Roivant itself and gaining access to select proprietary Roivant technology and other IP. This transaction was led by the Corporate Development team, where the role outlined in this job description sits. The sale of these Vants and technology assets represented over a 4x return on Roivant's investment.

Leveraging this proven model, we are evolving our mission and expanding capabilities to become a leader in novel modalities of drug development, and further establishing our position as the leading technology-enabled pharma company. We will redouble focus on acquiring potentially transformative assets in high value areas, while simultaneously augmenting our in-licensing model with capabilities in computational methods of drug discovery and tech-enabled development.

Today the Roivant family of companies spans therapeutics-focused Vants across a range of disease areas with robust pipelines, as well as data- and computational-focused capabilities in asset identification through drug development and commercialization.

Roivant is publicly listed and very well capitalized, with approximately $2.5bn of consolidated cash and cash equivalents as of September 30, 2021.

Position Summary:

The individual in this position will collaborate with Corporate Development colleagues to source, evaluate, analyze, and pitch multiple transaction theses. This includes working on meaningful deal workstreams, including due diligence, financial modeling, and communications. Potential transactions include acquisitions, divestitures, in-licensings, and out-licensings across a range of partnership structures, spanning companies, drug assets, and technologies. Corporate Development is particularly focused on opportunities that are potentially transformative to Roivant. This role will have meaningful exposure to leadership at Roivant and across the Vant family of companies and provides opportunities for capable individuals to quickly take on broader responsibility within the Corporate Development function

Responsibilities:

  • Evaluate the industry landscape to generate leads for potential M&A opportunities across the Vant family of companies
  • Conduct in-depth scientific, clinical and market research, and financial modeling to support recommendations
  • Construct persuasive transaction theses using Excel models and PowerPoint
  • Pitch transaction theses directly to senior management
  • Partner cross-functionally to assist with all elements of transactions on new investments through closing, including due diligence, valuation, deal structuring, and negotiations

Requirements:

  • 1-3 years' experience in a management consulting, equity research, or business development role focused on the biopharmaceutical industry
  • Strong financial modeling capabilities, including typical valuation methods and understanding of financial fundamentals required
  • Strategic understanding of the biopharmaceutical industry
  • Excellent written and verbal communication skills
  • Ability to work independently and collaboratively in a fast-paced, matrixed team environment consisting of internal and external team members
  • Ability to generate action through influence and engagement
  • Analytical thinker with excellent problem-solving skills and the ability to adapt to changing priorities and deadlines
  • Excellent planning, organization and time management skills including the ability to support and prioritize multiple projects
  • Bachelor's degree required